These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 34135858

  • 1. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J, Wu Y, Wu Z, Wu Y, Yang R, Liu Y, Lin H, Jiao X, Zhang Q.
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment.
    Hou X, Xing J, Shan H, Mei J, Sun Y, Yan G, Sun H, Wang J.
    Reprod Biomed Online; 2020 Nov; 41(5):845-853. PubMed ID: 32972873
    [Abstract] [Full Text] [Related]

  • 6. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
    Dong L, Lian F, Wu H, Xiang S, Li Y, Wei C, Yu X, Xin X.
    BMC Pregnancy Childbirth; 2022 Jul 22; 22(1):583. PubMed ID: 35869444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of adenomyosis types on clinical outcomes of IVF embryo transfer after ultra-long GnRH agonist protocol.
    Han B, Liang T, Zhang W, Ma C, Qiao J.
    Reprod Biomed Online; 2023 Feb 22; 46(2):346-351. PubMed ID: 36549997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ovulation induction with high progesterone levels may be more suitable for elderly patients with low ovarian response.
    Mu Z, Sa Y, Sun Z, Yi Y.
    J Gynecol Obstet Hum Reprod; 2021 Feb 22; 50(2):101661. PubMed ID: 31809957
    [Abstract] [Full Text] [Related]

  • 11. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 22; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 12. Effects of ovarian stimulation protocols on outcomes of assisted reproductive technology in adenomyosis women: a retrospective cohort study.
    Ge L, Li Y, Guan S, Cui L, Chen ZJ.
    Front Endocrinol (Lausanne); 2023 Jun 22; 14():1198779. PubMed ID: 37664864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET)].
    Tao T, Chen S, Chen X, Ye D, Xu L, Tian X, Liu Y, Niu J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb 22; 35(2):248-51. PubMed ID: 25736122
    [Abstract] [Full Text] [Related]

  • 15. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC, Engin Ustun Y.
    J Obstet Gynaecol; 2020 Aug 22; 40(6):837-842. PubMed ID: 31791167
    [Abstract] [Full Text] [Related]

  • 16. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.
    Kolanska K, Cohen J, Bendifallah S, Selleret L, Antoine JM, Chabbert-Buffet N, Darai E, d'Argent EM.
    J Gynecol Obstet Hum Reprod; 2017 Nov 22; 46(9):681-686. PubMed ID: 28970135
    [Abstract] [Full Text] [Related]

  • 17. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J, Sha A, Han D, Li P, Geng J, Ma C.
    Fertil Steril; 2014 Jul 22; 102(1):75-81. PubMed ID: 24746740
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD008046. PubMed ID: 21069701
    [Abstract] [Full Text] [Related]

  • 20. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 10; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.